Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganoderma Spore Lipids with Chemotherapy in GI Cancers
NCT02785523Phase 3Unknown
- Start
- May 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ganoderma spore lipids in gastrointestinal cancer (2 arms). Primary endpoints: Adverse Events at Cycle 6 and Quality of Life at Cycle 6. Status: unknown.
02
Drugs
ganoderma spore lipids
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on NCT02785523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785523.